Distributors Announce Proposed Opioid Settlement Will Proceed to Next Phase
Retrieved on:
Saturday, September 4, 2021
Biotechnology, Pharmaceutical, Medical Supplies, Health, FDA, Infectious Diseases, Hospitals, Clinical Trials, Health sciences, Health care, Health, McKesson Corporation, AmerisourceBergen, Cardinal Health, Pharmaceutical industry in China, Healthcare industry, Pharmacy, Pharmaceutical industry, Opioid epidemic in the United States, AmerisourceBergen, Cardinal Health, McKesson Corporation, AMERISOURCEBERGEN, CARDINAL HEALTH, MCKESSON CORPORATION
Under the proposed settlement agreement and process, all U.S. States, territories, and Washington DC were given 30 days to join the settlement, except West Virginia which settled previously with the companies.
Key Points:
- Under the proposed settlement agreement and process, all U.S. States, territories, and Washington DC were given 30 days to join the settlement, except West Virginia which settled previously with the companies.
- After the conclusion of the political subdivision sign-on period, each company will independently determine whether a sufficient number of political subdivisions have joined for the settlement to proceed to implementation.
- If the conditions are satisfied, the settlement would become effective 60 days after the distributors determine that there is sufficient participation to proceed.
- During this 60-day period, the participating states and the distributors would cooperate to obtain consent judgments in each participating state embodying the terms of the settlement.